EquityFlow
›
Companies
› Shift Bioscience
Shift Bioscience
Biotech
· Cambridge, GB
Biotech using generative AI to study and reverse cellular aging.
Funding history
Date
Round
Amount
Oct 2024
Seed
Shift Bioscience, a Cambridge aging-research biotech, raised a GBP12.5M (about $16M) seed led by BGF.
$16M
Investors
BGF
F-Prime Capital
Kindred Capital
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →